ReviewOncoimmunology2025

Chemoimmunomodulation in triple negative breast cancer: a key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy.

Mohammed O Gbadamosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.